Which SGA has a formulation available in both sublingual and transdermal patch?

The correct answer is asenapine, which is available in both sublingual and transdermal patch formulations. Asenapine is an atypical antipsychotic primarily used to treat schizophrenia and bipolar disorder. Its sublingual formulation allows for rapid absorption and onset of action, which can be particularly beneficial for patients requiring quick therapeutic effects. The transdermal patch offers a convenient and consistent delivery system, making it easier for patients to maintain medication adherence without the need to remember to take a daily oral dose.

This dual availability of formulations reflects the ongoing development of treatments that prioritize patient preferences and improve treatment adherence by providing alternative routes for medication delivery.